NCT00278980View on ClinicalTrials.gov

Effect of C-Peptide on Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

December 31, 2004

Conditions
Diabetes Mellitus, Type 1Diabetic Polyneuropathy
Interventions
DRUG

C-peptide

Trial Locations (1)

SE-171 76

Karolinska University Hospital Solna, Stockholm

All Listed Sponsors
lead

Creative Peptides Sweden Inc.

INDUSTRY

NCT00278980 - Effect of C-Peptide on Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter